FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/03/018069 [Registered on: 13/03/2019] Trial Registered Prospectively
Last Modified On: 11/03/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Radiofrequency Neuromodulation]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Radiofrequency ablation of genicular nerve versus saphenous nerve for chronic knee pain  
Scientific Title of Study   Pulsed radiofrequency ablation of genicular nerve versus saphenous nerve for relief in chronic knee pain: a prospective randomized study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Arghya Mukherjee 
Designation  Fellow, ESI Institute of Pain Management 
Affiliation  ESI Institute of Pain Management 
Address  Pain Management department, ESI Hosp[ital, Sealdah
301/3 APC Road, Kolkata 700009
Kolkata
WEST BENGAL
700009
India 
Phone  9830430936  
Fax    
Email  arghya.mukherjee5@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Subrata Goswami 
Designation  Course Director, EIPM 
Affiliation  ESI Institute of Pain Management 
Address  Pain Management Department, ESI Hospital, Sealdah 301/3 APC Road, Kolkata 700009.
301/3 APC Road, Kolkata 700009.
Kolkata
WEST BENGAL
700009
India 
Phone  9830430430  
Fax    
Email  drsgoswami@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Subrata Goswami 
Designation  Course Director, EIPM 
Affiliation  ESI Institute of Pain Management 
Address  Pain Management Department, ESI Hospital, Sealdah 301/3 APC Road, Kolkata 700009.
301/3 APC Road, Kolkata 700009.
Kolkata
WEST BENGAL
700009
India 
Phone  9830430430  
Fax    
Email  drsgoswami@gmail.com  
 
Source of Monetary or Material Support  
ESI Hospital, Sealdah 301/3 APC Road, Kolkata 700009 
 
Primary Sponsor  
Name  ESI Institute of Pain Management  
Address  ESI Hospital, Sealdah 301/3 APC Road, Kolkata 700009 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NA 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Subrata Goswami  ESI Hospital, Sealdah  ESI Institute of Pain Management, Pain Management Department, 301/3 APC Road, Kolkata 700009
Kolkata
WEST BENGAL 
09830430430

drsgoswami@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, ESI Institute of Pain management  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M17||Osteoarthritis of knee,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Pulsed radiofrequency of knee genicular nerve  After positive diagnostic block under fluoroscopy guidance pulsed RF ablation of the affected side supero-medial, supero-later and infero-medial quadrant of knee, at 42 degree celsius for 4 minutes for each point. 
Comparator Agent  Pulsed Radiofrequency of Saphenous nerve  After positive diagnostic block under ultrasonography guidance pulsed RF ablation of the affected side saphenous nerve at 42 degree celsius for 8 minutes. 
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1) Age between 25 and 65 years.
2) Chronic knee pain (more than 3 months duration).
3) Intensity of pain more than 4 according to VAS.
4) Pain predominantly involving medial compartment of knee joint.
 
 
ExclusionCriteria 
Details  1) Neurological deficit in lower limbs.
2) Prior knee replacement surgery any surgery with prosthesis implantation.
3) Diagnosed tumour or cancer involving knee.
4) Primary or metastatic spine tumor or spinal cord injury.
5) Leg pain due to PIVD.
6) Allergy to medications used in procedure.
7) Blood coagulation disorder.
8) Pregnancy.
9) Psychiatric illness
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
1) Pain in VAS Score
2) Functional improvement in WOMAC score 
Pre procedure and at 2 weeks, 6 weeks, 12 weeks and at 20 weeks post PRF treatment.  
 
Secondary Outcome  
Outcome  TimePoints 
Duration of Pain relief  Pre procedure and at 2 weeks, 6 weeks, 12 weeks and at 20 weeks post PRF treatment.  
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/03/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   None yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

This is a prospective randomized study to compare the efficacy of genicular nerve and saphenous nerve pulsed radiofrequency ablation (PRFA) for the relief of chronic knee pain. After obtaining proper informed consent, and maintaining the inclusion and exclusion criteria, 30 patients, over one year of study period there will be diagnostic block followed by PRFA procedure dividing the study population in two separate groups. Assessment of duration and quality of pain relief will be done followed by calculation by applying a specific formula mentioned, and will be expressed appropriately.

 
Close